1. Home
  2. ASNS vs INM Comparison

ASNS vs INM Comparison

Compare ASNS & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actelis Networks Inc.

ASNS

Actelis Networks Inc.

HOLD

Current Price

$0.09

Market Cap

1.9M

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.55

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASNS
INM
Founded
1998
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
2.1M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ASNS
INM
Price
$0.09
$1.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
57.8M
3.0M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,671,000.00
$4,942,633.00
Revenue This Year
$127.84
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.50
52 Week Low
$0.08
$0.58
52 Week High
$3.63
$7.98

Technical Indicators

Market Signals
Indicator
ASNS
INM
Relative Strength Index (RSI) 29.81 74.95
Support Level N/A $1.56
Resistance Level $0.53 $2.40
Average True Range (ATR) 0.08 0.15
MACD -0.02 0.08
Stochastic Oscillator 3.09 70.80

Price Performance

Historical Comparison
ASNS
INM

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: